SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
DE |
|
P
|
Polaris Inc
SWB:PL6
|
US |
Multiples-Based Value
The
Multiples-Based Value for
SCHOTT Pharma AG & Co KgaA (1SXP)
under the Base Case is
26.5
EUR.
Compared with the current market price of 13.92 EUR, the stock appears
Undervalued by 47%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
1SXP Competitors Multiples
SCHOTT Pharma AG & Co KgaA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
2.1B EUR | 2.1 | 13.9 | 7.9 | 11.3 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
992.2B USD | 347.4 | 4 113.7 | 1 178.7 | 2 269.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
186.6B USD | 4.2 | 27.8 | 19.3 | 25.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
134B USD | 5.5 | 37.1 | 18.9 | 27.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
316.8B CNY | 7 | 16.6 | 17.4 | 17.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.7B CHF | 5.3 | -126.3 | 17.1 | 27 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.5B USD | 4.6 | 25.2 | 18.5 | 21.9 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.4B USD | 9.9 | 48.8 | 31.5 | 39.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.4B USD | 1.7 | 21 | 11.7 | 17.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 6.7 | 31 | 23 | 25.5 |